---
title: COVID-19 Treatment Hopeful Enters New Phase
description: COVID-19 Treatment Hopeful Enters New Phase
---

[News ](https://www.yourway.com/news)

# [COVID-19 Treatment Hopeful Enters New Phase](https://www.yourway.com/news/covid-19-treatment-hopeful-enters-new-phase)

 Written by [Yourway](https://www.yourway.com/news/author/yourway) | August 25, 2020

Hopeful treatment for COVID-19, [remdesivir](https://www.nytimes.com/2020/08/18/health/Covid-treatments-remdesivir.html), which is made by Gilead Sciences, has entered a new stage of clinical trials. After findings revealed that remdesivir helps shorten the time patients are infected with coronavirus by four days, researchers now believe that when paired with anti-inflammatory drug interferon, that time will be reduced even further. A total of 1,000 participants in the phase III ACCT trial will receive either remdesivir and a placebo or remdesivir and beta interferon. Yourway has two decades of experience and a robust global footprint, which are key in clinical trial success.

[View full post](https://www.yourway.com/news/covid-19-treatment-hopeful-enters-new-phase)

```json
{
  "@context" : "http://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "Yourway"
  },
  "dateModified" : "2020-08-25T09:00:00.392Z",
  "datePublished" : "2020-08-25T09:00:00Z",
  "headline" : "COVID-19 Treatment Hopeful Enters New Phase",
  "image" : {
    "@type" : "ImageObject",
    "height" : 640,
    "url" : "https://f.hubspotusercontent30.net/hubfs/5402331/images/News_August/week_4/iStock-1254897750_02.jpg",
    "width" : 960
  },
  "mainEntityOfPage" : "https://www.yourway.com/news/covid-19-treatment-hopeful-enters-new-phase",
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "height" : 60,
      "url" : "/hs/hsstatic/content_shared_assets/static-1.4092/img/default-amp-logo.png",
      "width" : 60
    },
    "name" : "News"
  }
}
```